000 01432 a2200373 4500
005 20250514215412.0
264 0 _c20050401
008 200504s 0 0 eng d
022 _a1120-009X
024 7 _a10.1179/joc.2004.16.Supplement-1.70
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGarattini, E
245 0 0 _aAtypical retinoids: an expanding series of anti-leukemia and anti-cancer agents endowed with selective apoptotic activity.
_h[electronic resource]
260 _bJournal of chemotherapy (Florence, Italy)
_cNov 2004
300 _a70-3 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAntineoplastic Agents
_xchemistry
650 0 4 _aApoptosis
_xdrug effects
650 0 4 _aCell Line, Tumor
_xdrug effects
650 0 4 _aCell Survival
_xdrug effects
650 0 4 _aDNA Damage
_xdrug effects
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aLeukemia
_xdrug therapy
650 0 4 _aMale
650 0 4 _aMolecular Structure
650 0 4 _aNeoplasms
_xdrug therapy
650 0 4 _aRetinoids
_xpharmacology
650 0 4 _aSensitivity and Specificity
650 0 4 _aStructure-Activity Relationship
700 1 _aTerao, M
773 0 _tJournal of chemotherapy (Florence, Italy)
_gvol. 16 Suppl 4
_gp. 70-3
856 4 0 _uhttps://doi.org/10.1179/joc.2004.16.Supplement-1.70
_zAvailable from publisher's website
999 _c15365697
_d15365697